Edgewise Therapeutics (EWTX) has an average rating of buy and mean price target of $42.75, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Price: $39.52, Change: $+5.36, Percent Change: +15.69%